| cartilage development involved in endochondral bone morphogenesis | GO:0060351 | 24 | 0.577 | |
| extracellular structure organization | GO:0043062 | 148 | 0.383 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.360 | |
| connective tissue development | GO:0061448 | 179 | 0.323 | |
| recognition of apoptotic cell | GO:0043654 | 3 | 0.317 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.284 | |
| endochondral bone morphogenesis | GO:0060350 | 50 | 0.273 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.266 | |
| ossification | GO:0001503 | 216 | 0.258 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.241 | |
| response to growth factor | GO:0070848 | 198 | 0.233 | |
| cartilage development | GO:0051216 | 140 | 0.220 | |
| bone development | GO:0060348 | 120 | 0.210 | |
| lung development | GO:0030324 | 164 | 0.191 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.190 | |
| elastic fiber assembly | GO:0048251 | 4 | 0.186 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.184 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.176 | |
| response to inorganic substance | GO:0010035 | 96 | 0.173 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.164 | |
| bone morphogenesis | GO:0060349 | 78 | 0.149 | |
| growth plate cartilage development | GO:0003417 | 14 | 0.146 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.145 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.142 | |
| bone trabecula formation | GO:0060346 | 9 | 0.140 | |
| cellular response to amino acid stimulus | GO:0071230 | 29 | 0.135 | |
| chemotaxis | GO:0006935 | 247 | 0.133 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.128 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.123 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.120 | |
| skeletal system development | GO:0001501 | 356 | 0.113 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.113 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.110 | |
| trabecula formation | GO:0060343 | 24 | 0.106 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.105 | |
| cell adhesion | GO:0007155 | 329 | 0.103 | Human |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.102 | |
| renal system development | GO:0072001 | 225 | 0.102 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.099 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.099 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.092 | |
| response to acid chemical | GO:0001101 | 111 | 0.092 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.092 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.092 | |
| response to amino acid | GO:0043200 | 37 | 0.086 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.085 | |
| developmental maturation | GO:0021700 | 193 | 0.084 | |
| regulation of chondrocyte differentiation | GO:0032330 | 33 | 0.084 | |
| regulation of removal of superoxide radicals | GO:2000121 | 4 | 0.083 | |
| protein processing | GO:0016485 | 163 | 0.082 | |
| proteoglycan metabolic process | GO:0006029 | 38 | 0.081 | |
| sensory perception | GO:0007600 | 245 | 0.080 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.079 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.079 | |
| telencephalon development | GO:0021537 | 186 | 0.074 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.072 | |
| extrinsic apoptotic signaling pathway in absence of ligand | GO:0097192 | 55 | 0.071 | |
| endochondral bone growth | GO:0003416 | 19 | 0.071 | |
| regulation of cell motility | GO:2000145 | 236 | 0.065 | |
| physiological cardiac muscle hypertrophy | GO:0003301 | 3 | 0.065 | |
| urogenital system development | GO:0001655 | 261 | 0.064 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.063 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.062 | |
| muscle tissue development | GO:0060537 | 308 | 0.060 | |
| axon guidance | GO:0007411 | 141 | 0.060 | |
| kidney epithelium development | GO:0072073 | 121 | 0.060 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.060 | |
| oviduct development | GO:0060066 | 3 | 0.058 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.057 | |
| negative regulation of gastrulation | GO:2000542 | 3 | 0.056 | |
| bone trabecula morphogenesis | GO:0061430 | 12 | 0.056 | |
| digestive tract development | GO:0048565 | 190 | 0.056 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.056 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.055 | |
| lateral inhibition | GO:0046331 | 1 | 0.055 | |
| palate development | GO:0060021 | 76 | 0.054 | |
| ventricular cardiac muscle tissue development | GO:0003229 | 38 | 0.052 | |
| oxidation reduction process | GO:0055114 | 342 | 0.051 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.051 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.051 | |
| respiratory system development | GO:0060541 | 190 | 0.051 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.051 | |
| stem cell development | GO:0048864 | 219 | 0.050 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.050 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.049 | |
| limb development | GO:0060173 | 166 | 0.049 | |
| collagen fibril organization | GO:0030199 | 32 | 0.048 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.047 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 91 | 0.047 | |
| digestive system development | GO:0055123 | 200 | 0.046 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.046 | |
| regulation of cartilage development | GO:0061035 | 44 | 0.046 | |
| regulation of cell growth involved in cardiac muscle cell development | GO:0061050 | 3 | 0.045 | |
| protein oligomerization | GO:0051259 | 67 | 0.045 | |
| trabecula morphogenesis | GO:0061383 | 40 | 0.044 | |
| response to oxidative stress | GO:0006979 | 123 | 0.044 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.044 | |
| stem cell differentiation | GO:0048863 | 268 | 0.043 | |
| response to bmp | GO:0071772 | 14 | 0.043 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.042 | |
| skin development | GO:0043588 | 220 | 0.042 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.041 | |
| establishment of organ orientation | GO:0048561 | 1 | 0.041 | |
| aorta smooth muscle tissue morphogenesis | GO:0060414 | 2 | 0.040 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.040 | |
| cell chemotaxis | GO:0060326 | 81 | 0.040 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.039 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.039 | |
| protein heterotrimerization | GO:0070208 | 8 | 0.039 | |
| spermatogenesis | GO:0007283 | 284 | 0.038 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.038 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.038 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.037 | |
| removal of superoxide radicals | GO:0019430 | 12 | 0.037 | |
| physiological muscle hypertrophy | GO:0003298 | 3 | 0.037 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.037 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 82 | 0.036 | |
| limb morphogenesis | GO:0035108 | 149 | 0.036 | |
| ear development | GO:0043583 | 200 | 0.036 | |
| positive regulation of cell substrate adhesion | GO:0010811 | 47 | 0.036 | |
| fibril organization | GO:0097435 | 2 | 0.036 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.036 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.036 | |
| leukocyte migration | GO:0050900 | 124 | 0.035 | |
| respiratory tube development | GO:0030323 | 167 | 0.034 | |
| cell growth involved in cardiac muscle cell development | GO:0061049 | 3 | 0.034 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.034 | |
| regulation of cell migration | GO:0030334 | 219 | 0.034 | |
| regulation of endodermal cell differentiation | GO:1903224 | 2 | 0.034 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.034 | |
| tissue homeostasis | GO:0001894 | 115 | 0.034 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.034 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.033 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.033 | |
| neuron projection guidance | GO:0097485 | 141 | 0.033 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.033 | |
| head morphogenesis | GO:0060323 | 34 | 0.033 | |
| biomineral tissue development | GO:0031214 | 64 | 0.032 | |
| cellular response to oxygen radical | GO:0071450 | 14 | 0.032 | |
| mesenchyme development | GO:0060485 | 152 | 0.032 | |
| organ growth | GO:0035265 | 117 | 0.032 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.032 | |
| regionalization | GO:0003002 | 337 | 0.031 | |
| pallium development | GO:0021543 | 120 | 0.031 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.031 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.031 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.030 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.030 | |
| replacement ossification | GO:0036075 | 26 | 0.030 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.030 | |
| regulation of tissue remodeling | GO:0034103 | 38 | 0.029 | |
| positive regulation of epithelial cell proliferation involved in lung morphogenesis | GO:0060501 | 3 | 0.029 | |
| regulation of testosterone biosynthetic process | GO:2000224 | 2 | 0.029 | |
| anatomical structure maturation | GO:0071695 | 49 | 0.029 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.029 | |
| myeloid leukocyte migration | GO:0097529 | 57 | 0.029 | |
| heart morphogenesis | GO:0003007 | 178 | 0.028 | |
| regulation of transforming growth factor beta receptor signaling pathway | GO:0017015 | 43 | 0.028 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.028 | |
| cellular response to nitric oxide | GO:0071732 | 4 | 0.028 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.027 | |
| regulation of neuron migration | GO:2001222 | 22 | 0.027 | |
| positive regulation of bone resorption | GO:0045780 | 13 | 0.027 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.027 | |
| ear morphogenesis | GO:0042471 | 118 | 0.026 | |
| phagolysosome assembly | GO:0001845 | 3 | 0.026 | |
| forebrain development | GO:0030900 | 302 | 0.026 | |
| protein trimerization | GO:0070206 | 13 | 0.026 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.026 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.026 | |
| positive regulation of bone remodeling | GO:0046852 | 13 | 0.026 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.026 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.026 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.025 | |
| antibacterial peptide secretion | GO:0002779 | 1 | 0.025 | |
| establishment of planar polarity involved in nephron morphogenesis | GO:0072046 | 1 | 0.025 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.025 | |
| signal transduction in absence of ligand | GO:0038034 | 55 | 0.025 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.025 | |
| tissue remodeling | GO:0048771 | 102 | 0.024 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.024 | |
| female gamete generation | GO:0007292 | 74 | 0.024 | |
| cell maturation | GO:0048469 | 127 | 0.024 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.024 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.024 | |
| cell adhesion mediated by integrin | GO:0033627 | 18 | 0.024 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.023 | |
| cardiac chamber development | GO:0003205 | 108 | 0.023 | |
| positive regulation of anagen | GO:0051885 | 1 | 0.023 | |
| organelle fission | GO:0048285 | 170 | 0.023 | |
| metanephric loop of henle development | GO:0072236 | 4 | 0.023 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.023 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.023 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.023 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.023 | |
| formation of primary germ layer | GO:0001704 | 77 | 0.022 | |
| regulation of bone resorption | GO:0045124 | 24 | 0.022 | |
| cellular response to superoxide | GO:0071451 | 14 | 0.022 | |
| kidney development | GO:0001822 | 213 | 0.022 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.022 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.022 | |
| aorta development | GO:0035904 | 23 | 0.022 | |
| antimicrobial peptide secretion | GO:0002776 | 1 | 0.022 | |
| paramesonephric duct development | GO:0061205 | 3 | 0.021 | |
| protein catabolic process | GO:0030163 | 221 | 0.021 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.021 | |
| superoxide metabolic process | GO:0006801 | 27 | 0.021 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.021 | |
| skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration | GO:0014834 | 3 | 0.021 | |
| membrane organization | GO:0061024 | 245 | 0.021 | |
| canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation | GO:0044343 | 1 | 0.021 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.021 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.021 | |
| response to nitric oxide | GO:0071731 | 4 | 0.021 | |
| nephron epithelium development | GO:0072009 | 92 | 0.021 | |
| midbrain hindbrain boundary maturation | GO:0021732 | 1 | 0.021 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.020 | |
| bone mineralization | GO:0030282 | 54 | 0.020 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.020 | |
| testosterone biosynthetic process | GO:0061370 | 2 | 0.020 | |
| gastrulation | GO:0007369 | 116 | 0.020 | |
| cerebral cortex development | GO:0021987 | 86 | 0.020 | |
| multicellular organismal catabolic process | GO:0044243 | 7 | 0.020 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.020 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.019 | |
| sensory perception of mechanical stimulus | GO:0050954 | 107 | 0.019 | |
| wnt signaling pathway involved in forebrain neuroblast division | GO:0021874 | 2 | 0.019 | |
| gland development | GO:0048732 | 330 | 0.019 | |
| positive regulation of neuron projection development | GO:0010976 | 79 | 0.019 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.019 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.019 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.019 | |
| epidermis development | GO:0008544 | 187 | 0.019 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.019 | |
| midgut development | GO:0007494 | 4 | 0.019 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.019 | |
| antibacterial peptide production | GO:0002778 | 2 | 0.019 | |
| rac protein signal transduction | GO:0016601 | 13 | 0.019 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.019 | |
| regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation | GO:2000079 | 1 | 0.019 | |
| oocyte axis specification | GO:0007309 | 2 | 0.019 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.018 | |
| nephron tubule morphogenesis | GO:0072078 | 68 | 0.018 | |
| chromatin organization | GO:0006325 | 206 | 0.018 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.018 | |
| face development | GO:0060324 | 38 | 0.018 | |
| nuclear division | GO:0000280 | 158 | 0.018 | |
| negative regulation of ossification | GO:0030279 | 49 | 0.018 | |
| antimicrobial peptide biosynthetic process | GO:0002777 | 2 | 0.018 | |
| trachea cartilage morphogenesis | GO:0060535 | 4 | 0.018 | |
| spemann organizer formation at the anterior end of the primitive streak | GO:0060064 | 1 | 0.018 | |
| mesonephros development | GO:0001823 | 97 | 0.018 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.018 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.018 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.018 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.017 | |
| neuron migration | GO:0001764 | 122 | 0.017 | |
| positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation | GO:2000081 | 1 | 0.017 | |
| oocyte construction | GO:0007308 | 2 | 0.017 | |
| regulation of interleukin 8 secretion | GO:2000482 | 2 | 0.017 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.017 | |
| protein maturation | GO:0051604 | 176 | 0.017 | |
| positive regulation of tissue remodeling | GO:0034105 | 19 | 0.017 | |
| notochord development | GO:0030903 | 20 | 0.017 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.017 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.017 | |
| artery development | GO:0060840 | 53 | 0.017 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.017 | |
| regulation of protein localization | GO:0032880 | 231 | 0.017 | |
| insulin processing | GO:0030070 | 2 | 0.017 | |
| negative regulation of extrinsic apoptotic signaling pathway in absence of ligand | GO:2001240 | 16 | 0.017 | |
| dendrite development | GO:0016358 | 115 | 0.016 | |
| germ cell development | GO:0007281 | 185 | 0.016 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.016 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.016 | |
| inflammatory response | GO:0006954 | 244 | 0.016 | |
| peptide metabolic process | GO:0006518 | 46 | 0.016 | |
| hexose biosynthetic process | GO:0019319 | 39 | 0.016 | |
| cell fate commitment | GO:0045165 | 210 | 0.016 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.016 | |
| defense response to bacterium | GO:0042742 | 119 | 0.016 | |
| cardiac ventricle morphogenesis | GO:0003208 | 50 | 0.016 | |
| protein heterooligomerization | GO:0051291 | 14 | 0.016 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.016 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.016 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.016 | |
| cell cell adhesion | GO:0098609 | 41 | 0.016 | |
| multicellular organism growth | GO:0035264 | 161 | 0.016 | |
| regulation of ossification | GO:0030278 | 112 | 0.016 | |
| endocytosis | GO:0006897 | 168 | 0.016 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.016 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.016 | |
| cellular response to bmp stimulus | GO:0071773 | 14 | 0.016 | |
| regulation of chemotaxis | GO:0050920 | 53 | 0.015 | |
| nephron tubule development | GO:0072080 | 84 | 0.015 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.015 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.015 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.015 | |
| histone modification | GO:0016570 | 159 | 0.015 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.015 | |
| male gamete generation | GO:0048232 | 285 | 0.015 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.015 | |
| positive regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045899 | 2 | 0.015 | |
| negative regulation of signal transduction in absence of ligand | GO:1901099 | 16 | 0.015 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.015 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.014 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.014 | |
| axonogenesis | GO:0007409 | 274 | 0.014 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.014 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.014 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.014 | |
| regulation of protein processing | GO:0070613 | 96 | 0.014 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.014 | |
| nerve development | GO:0021675 | 67 | 0.014 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.014 | |
| chromatin modification | GO:0016568 | 187 | 0.014 | |
| kidney rudiment formation | GO:0072003 | 3 | 0.014 | |
| regulation of ketone biosynthetic process | GO:0010566 | 2 | 0.014 | |
| spinal cord ventral commissure morphogenesis | GO:0021965 | 2 | 0.014 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.014 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.014 | |
| non canonical wnt signaling pathway involved in heart development | GO:0061341 | 3 | 0.014 | |
| negative regulation of growth | GO:0045926 | 99 | 0.014 | |
| direct ossification | GO:0036072 | 5 | 0.014 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.014 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.014 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.014 | |
| negative regulation of angiogenesis | GO:0016525 | 25 | 0.014 | |
| type b pancreatic cell proliferation | GO:0044342 | 10 | 0.014 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.014 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.013 | |
| negative regulation of macrophage chemotaxis | GO:0010760 | 1 | 0.013 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.013 | |
| mesoderm development | GO:0007498 | 100 | 0.013 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.013 | |
| cation homeostasis | GO:0055080 | 212 | 0.013 | |
| multicellular organismal macromolecule metabolic process | GO:0044259 | 19 | 0.013 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.013 | |
| planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | GO:0061350 | 2 | 0.013 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.013 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.013 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.013 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.013 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.013 | |
| renal tubule morphogenesis | GO:0061333 | 72 | 0.013 | |
| amine metabolic process | GO:0009308 | 45 | 0.013 | |
| ventricular cardiac muscle tissue morphogenesis | GO:0055010 | 32 | 0.013 | |
| epithelial tube formation | GO:0072175 | 130 | 0.013 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.013 | |
| interleukin 8 secretion | GO:0072606 | 3 | 0.013 | |
| somatic sex determination | GO:0018993 | 2 | 0.013 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.013 | |
| regulation of thymocyte migration | GO:2000410 | 2 | 0.013 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.013 | |
| regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045898 | 2 | 0.013 | |
| female sex determination | GO:0030237 | 1 | 0.013 | |
| positive regulation of synaptic growth at neuromuscular junction | GO:0045887 | 1 | 0.013 | |
| lung alveolus development | GO:0048286 | 45 | 0.013 | |
| skin morphogenesis | GO:0043589 | 38 | 0.013 | |
| oocyte differentiation | GO:0009994 | 35 | 0.012 | |
| endothelial cell apoptotic process | GO:0072577 | 9 | 0.012 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.012 | |
| response to pain | GO:0048265 | 26 | 0.012 | |
| cytokine production | GO:0001816 | 319 | 0.012 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.012 | |
| negative regulation of cell substrate adhesion | GO:0010812 | 16 | 0.012 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.012 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.012 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.012 | |
| regulation of bone remodeling | GO:0046850 | 28 | 0.012 | |
| endodermal cell differentiation | GO:0035987 | 14 | 0.012 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.012 | |
| regulation of anagen | GO:0051884 | 1 | 0.012 | |
| leukocyte chemotaxis | GO:0030595 | 69 | 0.012 | |
| gliogenesis | GO:0042063 | 141 | 0.012 | |
| hypophysis morphogenesis | GO:0048850 | 3 | 0.012 | |
| regulation of jnk cascade | GO:0046328 | 62 | 0.012 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.012 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.012 | |
| extracellular matrix assembly | GO:0085029 | 12 | 0.012 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.012 | |
| compound eye development | GO:0048749 | 1 | 0.012 | |
| camera type eye development | GO:0043010 | 266 | 0.012 | |
| regulation of cellular response to oxidative stress | GO:1900407 | 19 | 0.012 | |
| non canonical wnt signaling pathway via mapk cascade | GO:0038030 | 3 | 0.012 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.012 | |
| actin filament organization | GO:0007015 | 113 | 0.012 | |
| lateral ganglionic eminence cell proliferation | GO:0022018 | 1 | 0.012 | |
| fertilization | GO:0009566 | 127 | 0.012 | |
| positive regulation of interleukin 6 secretion | GO:2000778 | 1 | 0.012 | |
| cell recognition | GO:0008037 | 83 | 0.012 | |
| anion transport | GO:0006820 | 177 | 0.012 | |
| lysosome organization | GO:0007040 | 21 | 0.012 | |
| establishment of anatomical structure orientation | GO:0048560 | 1 | 0.011 | |
| negative regulation of androgen biosynthetic process | GO:2000180 | 1 | 0.011 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.011 | |
| proteasomal protein catabolic process | GO:0010498 | 98 | 0.011 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.011 | |
| regulation of protein transport | GO:0051223 | 163 | 0.011 | |
| mapk cascade | GO:0000165 | 281 | 0.011 | |
| positive regulation of rho protein signal transduction | GO:0035025 | 7 | 0.011 | |
| androgen biosynthetic process | GO:0006702 | 4 | 0.011 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.011 | |
| mitochondrion organization | GO:0007005 | 134 | 0.011 | |
| regulation of asymmetric cell division | GO:0009786 | 4 | 0.011 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.011 | |
| actin filament bundle assembly | GO:0051017 | 40 | 0.011 | |
| negative regulation of chemotaxis | GO:0050922 | 11 | 0.011 | |
| regulation of endothelial cell apoptotic process | GO:2000351 | 9 | 0.011 | |
| growth involved in heart morphogenesis | GO:0003241 | 4 | 0.011 | |
| negative regulation of vasculature development | GO:1901343 | 26 | 0.011 | |
| transmembrane transport | GO:0055085 | 412 | 0.011 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.011 | |
| rna interference | GO:0016246 | 2 | 0.011 | |
| antimicrobial peptide production | GO:0002775 | 2 | 0.011 | |
| canonical wnt signaling pathway involved in regulation of cell proliferation | GO:0044340 | 3 | 0.011 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 40 | 0.011 | |
| interleukin 8 production | GO:0032637 | 4 | 0.011 | |
| planar cell polarity pathway involved in ventricular septum morphogenesis | GO:0061348 | 2 | 0.011 | |
| metanephric glomerular basement membrane development | GO:0072274 | 1 | 0.011 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.011 | |
| positive regulation of neuron projection regeneration | GO:0070572 | 2 | 0.011 | |
| epithelial cell morphogenesis | GO:0003382 | 41 | 0.011 | |
| protein ubiquitination | GO:0016567 | 171 | 0.011 | |
| endomembrane system organization | GO:0010256 | 147 | 0.011 | |
| positive regulation of fatty acid oxidation | GO:0046321 | 4 | 0.011 | |
| epithelial cell development | GO:0002064 | 159 | 0.011 | |
| negative regulation of extrinsic apoptotic signaling pathway | GO:2001237 | 45 | 0.011 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.011 | |
| positive regulation of peptidase activity | GO:0010952 | 49 | 0.011 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.011 | |
| lateral sprouting involved in mammary gland duct morphogenesis | GO:0060599 | 2 | 0.011 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.011 | |
| glucose homeostasis | GO:0042593 | 128 | 0.011 | |
| positive regulation of transforming growth factor beta receptor signaling pathway | GO:0030511 | 12 | 0.011 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.011 | |
| positive regulation of neuron apoptotic process | GO:0043525 | 25 | 0.011 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.011 | |
| collagen metabolic process | GO:0032963 | 17 | 0.011 | |
| body morphogenesis | GO:0010171 | 45 | 0.010 | |
| odontogenesis | GO:0042476 | 78 | 0.010 | |
| regulation of extrinsic apoptotic signaling pathway in absence of ligand | GO:2001239 | 26 | 0.010 | |
| maintenance of cell number | GO:0098727 | 3 | 0.010 | |
| nephron development | GO:0072006 | 109 | 0.010 | |
| neural retina development | GO:0003407 | 41 | 0.010 | |
| mesonephric duct morphogenesis | GO:0072180 | 4 | 0.010 | |
| ubiquitin dependent smad protein catabolic process | GO:0030579 | 2 | 0.010 | |
| myoblast differentiation involved in skeletal muscle regeneration | GO:0014835 | 3 | 0.010 | |
| dendritic spine maintenance | GO:0097062 | 4 | 0.010 | |
| positive regulation of cell cell adhesion mediated by cadherin | GO:2000049 | 2 | 0.010 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.010 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.010 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.010 | |
| cerebellar cortex development | GO:0021695 | 48 | 0.010 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.010 | |
| defense response to other organism | GO:0098542 | 197 | 0.010 | |
| cerebellum formation | GO:0021588 | 1 | 0.010 | |
| exocytosis | GO:0006887 | 121 | 0.010 | |
